الوصف
Anti-inflammatory effects of berberine in hepatic tissue from NAFLD models reveal reduced expression of pro-inflammatory cytokines including TNF-alpha, IL-6, and NF-kB pathway components.
Figure 14
ChartSource Paper
Berberine Effects in Pre-Fibrotic Stages of Non-Alcoholic Fatty Liver Disease-Clinical and Pre-Clinical Overview and Systematic Review of the Literature.Cite This Figure
![Figure 14: Anti-inflammatory effects of berberine in hepatic tissue from NAFLD models reveal reduced expression of pro-inflammatory cytokines including TNF-alpha, IL-6, and NF-kB pathway components.]() > Source: Florentina Ionita-Radu et al. "Berberine Effects in Pre-Fibrotic Stages of Non-Alcoholic Fatty Liver Disease-Cl." *International journal of molecular sciences*, 2024. PMID: [38673787](https://pubmed.ncbi.nlm.nih.gov/38673787/)
<figure> <img src="" alt="Anti-inflammatory effects of berberine in hepatic tissue from NAFLD models reveal reduced expression of pro-inflammatory cytokines including TNF-alpha, IL-6, and NF-kB pathway components." /> <figcaption>Figure 14. Anti-inflammatory effects of berberine in hepatic tissue from NAFLD models reveal reduced expression of pro-inflammatory cytokines including TNF-alpha, IL-6, and NF-kB pathway components.<br> Source: Florentina Ionita-Radu et al. "Berberine Effects in Pre-Fibrotic Stages of Non-Alcoholic Fatty Liver Disease-Cl." <em>International journal of molecular sciences</em>, 2024. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/38673787/">38673787</a></figcaption> </figure>